Mankind Pharma Limited (NSE:MANKIND)
2,080.70
+20.20 (0.98%)
Feb 16, 2026, 1:20 PM IST
-13.10% (1Y)
| Market Cap | 850.58B -16.0% |
| Revenue (ttm) | 139.14B +19.5% |
| Net Income | 17.79B -12.8% |
| EPS | 43.10 -15.2% |
| Shares Out | 412.81M |
| PE Ratio | 47.69 |
| Forward PE | 36.50 |
| Dividend | 2.00 (0.10%) |
| Ex-Dividend Date | n/a |
| Volume | 102,784 |
| Average Volume | 377,004 |
| Open | 2,055.00 |
| Previous Close | 2,060.50 |
| Day's Range | 2,051.70 - 2,085.40 |
| 52-Week Range | 2,033.00 - 2,716.50 |
| Beta | 0.15 |
| RSI | 44.70 |
| Earnings Date | Feb 3, 2026 |